Development and characterisation of aptamers as inhibitors of vital pathways in cancer therapy

Khan, Huma; Makwana, Vaidehi; Courtenay-Luck, Nigel and Missailidis, Sotiris (2008). Development and characterisation of aptamers as inhibitors of vital pathways in cancer therapy. Anticancer Research, 28(5C) pp. 3346–3347.

URL:	http://ar.iiarjournals.org/content/28/5C
Google Scholar:	Look up in Google Scholar

Abstract

Aptamers can be described as short oligonucleotides that harbour great potential in their versatile applications, due to their high affinity and specificity for their target of choice. Despite their infancy, aptamers have already emerged at the forefront of clinical research, offering significant contribution as therapeutic agents for a range of diseases. Thus, our research is aimed towards generating aptamer(s) for a specific cancer biomarker that, when blocked, can lead to specific cell kill and thus offer a novel therapeutic potential against cancer.

Item Type:	Article
Copyright Holders:	2008 Anticancer Research
ISSN:	1791-7530
Extra Information:	Abstracts of the 8th International Conference of Anticancer Research, 17-22 October 2008, Kos, Greece
Academic Unit/School:	Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences Faculty of Science, Technology, Engineering and Mathematics (STEM)
Interdisciplinary Research Centre:	Biomedical Research Network (BRN)
Item ID:	26047
Depositing User:	Sotiris Missailidis
Date Deposited:	09 Jan 2011 12:34
Last Modified:	04 Oct 2016 10:54
URI:	http://oro.open.ac.uk/id/eprint/26047
Share this page:

▼ Automated document suggestions from open access sources

Actions (login may be required)

Policies | Disclaimer